• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直肠癌经肛门全直肠系膜切除术(TaTME)和腹腔镜全直肠系膜切除术(LapTME)后术后磁共振成像的残留系膜。

Residual mesorectum on postoperative magnetic resonance imaging following transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LapTME) in rectal cancer.

机构信息

Department of Surgery, VU University Medical Centre, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

Department of Surgery, Gelderse Vallei Hospital, Ede, The Netherlands.

出版信息

Surg Endosc. 2019 Jan;33(1):94-102. doi: 10.1007/s00464-018-6279-9. Epub 2018 Jul 2.

DOI:10.1007/s00464-018-6279-9
PMID:29967990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6336750/
Abstract

BACKGROUND

The standard treatment for mid- and low-rectal cancer is total mesorectal excision. Incomplete excision is an important predictor of local recurrence after rectal cancer surgery. Transanal TME (TaTME) is a new treatment option in which the rectum is approached with both laparoscopic and transanal endoscopic techniques. The aim of the present study was to determine the prevalence and localisation of residual mesorectal tissue by postoperative magnetic resonance imaging (MRI) of the pelvis and compare this between TaTME and laparoscopic TME (LapTME) patients. In addition, we assessed correspondence with histopathological quality.

METHODS

Two groups of patients with cT1-T3 rectal cancer who underwent TME surgery with primary anastomosis were included, each group consisting of 32 patients. Postoperative T2-weighted MRI of the pelvis was performed at least 6 months after TME surgery and evaluated by two radiologists independently. Residual mesorectum was defined as any residual mesorectal tissue detectable after TME. Localisation of the tissue was categorised in relation to height in the pelvis and position of the level of anastomosis.

RESULTS

Residual mesorectal tissue was detected in 3.1% of TaTME patients and of 46.9% in LapTME patients (p < 0.001). Multivariate analysis identified only type of surgery as a significant risk factor for leaving residual mesorectum. Other known risk factors for incomplete TME, such as body mass index (BMI) and male gender, were not significant. No relation was seen between specimen quality and prevalence of residual mesorectum.

CONCLUSIONS

The completeness of mesorectal excision was significantly better with TaTME than with standard laparoscopic technique.

摘要

背景

中低位直肠肿瘤的标准治疗方法是全直肠系膜切除术。直肠癌手术后局部复发的一个重要预测因素是切除不完整。经肛门全直肠系膜切除术(TaTME)是一种新的治疗选择,它采用腹腔镜和经肛门内镜技术来接近直肠。本研究的目的是通过术后骨盆磁共振成像(MRI)确定残留直肠系膜组织的发生率和定位,并将其与 TaTME 和腹腔镜全直肠系膜切除术(LapTME)患者进行比较。此外,我们还评估了与组织病理学质量的一致性。

方法

纳入了两组接受 TME 手术加原发性吻合术的 cT1-T3 直肠肿瘤患者,每组 32 例。TME 手术后至少 6 个月进行盆腔 T2 加权 MRI,由两位放射科医生独立评估。残留直肠系膜定义为 TME 后可检测到的任何残留直肠系膜组织。组织的定位与骨盆的高度和吻合口的位置有关。

结果

TaTME 患者中残留直肠系膜组织的检出率为 3.1%,LapTME 患者中为 46.9%(p<0.001)。多因素分析仅发现手术类型是残留直肠系膜的一个显著危险因素。其他已知的 TME 不完整的危险因素,如体重指数(BMI)和男性性别,没有显著意义。标本质量与残留直肠系膜的发生率之间没有关系。

结论

TaTME 比标准腹腔镜技术的直肠系膜切除完整性要好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab9/6336750/4a748f8e5a11/464_2018_6279_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab9/6336750/7262c9f9d944/464_2018_6279_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab9/6336750/e281a09694b7/464_2018_6279_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab9/6336750/48cac74978eb/464_2018_6279_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab9/6336750/4a748f8e5a11/464_2018_6279_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab9/6336750/7262c9f9d944/464_2018_6279_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab9/6336750/e281a09694b7/464_2018_6279_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab9/6336750/48cac74978eb/464_2018_6279_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab9/6336750/4a748f8e5a11/464_2018_6279_Fig4_HTML.jpg

相似文献

1
Residual mesorectum on postoperative magnetic resonance imaging following transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LapTME) in rectal cancer.直肠癌经肛门全直肠系膜切除术(TaTME)和腹腔镜全直肠系膜切除术(LapTME)后术后磁共振成像的残留系膜。
Surg Endosc. 2019 Jan;33(1):94-102. doi: 10.1007/s00464-018-6279-9. Epub 2018 Jul 2.
2
Outcomes of open vs laparoscopic vs robotic vs transanal total mesorectal excision (TME) for rectal cancer: a network meta-analysis.直肠癌开放手术、腹腔镜手术、机器人手术与经肛门全直肠系膜切除术(TME)的疗效:一项网状Meta分析。
Tech Coloproctol. 2023 May;27(5):345-360. doi: 10.1007/s10151-022-02739-1. Epub 2022 Dec 12.
3
Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.经肛门全直肠系膜切除术(TaTME)与 MRI 定义低位直肠癌的腹腔镜 TME 比较:基于倾向评分匹配的肿瘤学结局分析。
Surg Endosc. 2019 Aug;33(8):2459-2467. doi: 10.1007/s00464-018-6530-4. Epub 2018 Oct 22.
4
Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer.经肛门和腹腔镜直肠癌全直肠系膜切除术后的短期结局
Tech Coloproctol. 2016 Apr;20(4):227-34. doi: 10.1007/s10151-015-1421-3. Epub 2016 Jan 21.
5
Transanal Versus Laparoscopic Total Mesorectal Excision: A Comparative Prospective Clinical Trial from Two Centers.经肛门与腹腔镜全直肠系膜切除术:来自两个中心的比较性前瞻性临床试验
J Laparoendosc Adv Surg Tech A. 2020 Jul;30(7):769-776. doi: 10.1089/lap.2019.0828. Epub 2020 Apr 2.
6
Simple instruments facilitating achievement of transanal total mesorectal excision in male patients.便于男性患者经肛门全直肠系膜切除术的简单器械。
World J Gastroenterol. 2017 Aug 21;23(31):5798-5808. doi: 10.3748/wjg.v23.i31.5798.
7
Comparison of pathological outcomes after transanal versus laparoscopic total mesorectal excision: a prospective study using data from randomized control trial.经肛门与腹腔镜全直肠系膜切除术的病理结果比较:一项基于随机对照试验数据的前瞻性研究。
Surg Endosc. 2020 Sep;34(9):3956-3962. doi: 10.1007/s00464-019-07167-1. Epub 2019 Oct 4.
8
Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A meta-analysis.经肛门与腹腔镜全直肠系膜切除术治疗中低位直肠癌的短期临床疗效比较:一项荟萃分析。
Eur J Surg Oncol. 2016 Dec;42(12):1841-1850. doi: 10.1016/j.ejso.2016.09.002. Epub 2016 Sep 19.
9
Transanal (TaTME) vs. laparoscopic total mesorectal excision for mid and low rectal cancer: a propensity score-matched analysis of early and long-term outcomes.经肛门(TaTME)与腹腔镜全直肠系膜切除术治疗中低位直肠癌:早期和长期结局的倾向评分匹配分析。
Int J Colorectal Dis. 2021 Oct;36(10):2271-2279. doi: 10.1007/s00384-021-04019-0. Epub 2021 Sep 1.
10
COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.COLOR III:一项比较经肛门全直肠系膜切除术与腹腔镜全直肠系膜切除术治疗中低位直肠癌的多中心随机临床试验。
Surg Endosc. 2016 Aug;30(8):3210-5. doi: 10.1007/s00464-015-4615-x. Epub 2015 Nov 4.

引用本文的文献

1
Roles of MRI evaluation of pelvic recurrence in patients with rectal cancer.MRI评估直肠癌患者盆腔复发的作用。
Insights Imaging. 2024 Nov 11;15(1):270. doi: 10.1186/s13244-024-01842-1.
2
Laparoscopic total mesorectal excision versus transanal total mesorectal excision for mid and low rectal cancer: A systematic review and meta-analysis.腹腔镜全直肠系膜切除术与经肛门全直肠系膜切除术治疗中低位直肠癌的系统评价和Meta分析
Medicine (Baltimore). 2024 Jan 26;103(4):e36859. doi: 10.1097/MD.0000000000036859.
3
A systematic review and meta-analysis of minimally invasive total mesorectal excision versus transanal total mesorectal excision for mid and low rectal cancer.

本文引用的文献

1
Transanal total mesorectal excision (TaTME) for rectal cancer: Step by step description of the surgical technique for a two-teams approach.经肛门全直肠系膜切除术(TaTME)治疗直肠癌:双团队手术技术的分步描述
Eur J Surg Oncol. 2017 Feb;43(2):502-505. doi: 10.1016/j.ejso.2016.10.024. Epub 2016 Nov 20.
2
Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review.经肛门全直肠系膜切除术治疗直肠癌的临床结局及病例数量效应:一项系统评价
Tech Coloproctol. 2016 Dec;20(12):811-824. doi: 10.1007/s10151-016-1545-0. Epub 2016 Nov 16.
3
COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.
微创全直肠系膜切除术与经肛门全直肠系膜切除术治疗中低位直肠癌的系统评价和Meta分析
Front Oncol. 2023 Jun 12;13:1167200. doi: 10.3389/fonc.2023.1167200. eCollection 2023.
4
Surgical Outcomes, Long-Term Recurrence Rate, and Resource Utilization in a Prospective Cohort of 165 Patients Treated by Transanal Total Mesorectal Excision for Distal Rectal Cancer.经肛门全直肠系膜切除术治疗165例低位直肠癌患者的前瞻性队列研究中的手术结果、长期复发率及资源利用情况
Cancers (Basel). 2023 Feb 13;15(4):1190. doi: 10.3390/cancers15041190.
5
Laparoscopic intersphincteric resection vs. transanal total mesorectal excision in overweight patients with low rectal cancer.超重低位直肠癌患者行腹腔镜括约肌间切除术与经肛门全直肠系膜切除术的比较
Front Surg. 2022 Oct 6;9:984680. doi: 10.3389/fsurg.2022.984680. eCollection 2022.
6
Required distal mesorectal resection margin in partial mesorectal excision: a systematic review on distal mesorectal spread.部分直肠系膜切除时需要远端直肠系膜切缘:远端直肠系膜扩散的系统评价。
Tech Coloproctol. 2023 Jan;27(1):11-21. doi: 10.1007/s10151-022-02690-1. Epub 2022 Aug 29.
7
Mesentery in Transanal TME.经肛门全直肠系膜切除术中的系膜
Clin Colon Rectal Surg. 2022 Aug 10;35(4):306-315. doi: 10.1055/s-0042-1748887. eCollection 2022 Jul.
8
Structured training curriculums for transanal total mesorectal excision in China: refinement is needed.中国经肛门全直肠系膜切除术的结构化培训课程:仍需完善。
Ann Transl Med. 2022 Apr;10(8):489. doi: 10.21037/atm-22-1693.
9
Impact of Surgical Approach on Surgical Resection Quality in Mid- and Low Rectal Cancer, A Bayesian Network Meta-Analysis.手术方式对中低位直肠癌手术切除质量的影响:一项贝叶斯网络荟萃分析
Front Oncol. 2021 Aug 11;11:699200. doi: 10.3389/fonc.2021.699200. eCollection 2021.
10
Transperineal total mesorectal excision for rectal cancer on the residual rectum after multiple abdominal surgeries in a patient with Crohn's disease: a case report.克罗恩病患者多次腹部手术后经会阴行直肠癌全直肠系膜切除术:一例报告
Surg Case Rep. 2021 May 13;7(1):122. doi: 10.1186/s40792-021-01206-7.
COLOR III:一项比较经肛门全直肠系膜切除术与腹腔镜全直肠系膜切除术治疗中低位直肠癌的多中心随机临床试验。
Surg Endosc. 2016 Aug;30(8):3210-5. doi: 10.1007/s00464-015-4615-x. Epub 2015 Nov 4.
4
Transanal Total Mesorectal Excision for Rectal Cancer: Outcomes after 140 Patients.经肛门全直肠系膜切除术治疗直肠癌:140 例患者的结果。
J Am Coll Surg. 2015 Aug;221(2):415-23. doi: 10.1016/j.jamcollsurg.2015.03.046. Epub 2015 Mar 30.
5
Transanal total mesorectal excision for rectal carcinoma: short-term outcomes and experience after 80 cases.经肛门全直肠系膜切除术治疗直肠癌:80例患者的短期疗效及经验
Surg Endosc. 2016 Feb;30(2):464-470. doi: 10.1007/s00464-015-4221-y. Epub 2015 Apr 29.
6
A randomized trial of laparoscopic versus open surgery for rectal cancer.腹腔镜与开腹手术治疗直肠癌的随机对照研究。
N Engl J Med. 2015 Apr 2;372(14):1324-32. doi: 10.1056/NEJMoa1414882.
7
Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery.经肛门全直肠系膜切除术治疗直肠癌:与腹腔镜手术的短期疗效比较。
Ann Surg. 2015 Feb;261(2):221-7. doi: 10.1097/SLA.0000000000000865.
8
Transanal versus traditional laparoscopic total mesorectal excision for rectal carcinoma.经肛门与传统腹腔镜全直肠系膜切除术治疗直肠癌的比较
Surg Endosc. 2014 Dec;28(12):3494-9. doi: 10.1007/s00464-014-3636-1. Epub 2014 Jun 28.
9
Transanal minimally invasive surgery for total mesorectal excision (TAMIS-TME): results and experience with the first 20 patients undergoing curative-intent rectal cancer surgery at a single institution.经肛门全直肠系膜切除术(TAMIS-TME):单机构首例20例接受根治性直肠癌手术患者的结果与经验
Tech Coloproctol. 2014 May;18(5):473-80. doi: 10.1007/s10151-013-1095-7. Epub 2013 Nov 23.
10
Extent and completeness of mesorectal excision evaluated by postoperative magnetic resonance imaging.术后磁共振成像评估中直肠系膜切除的范围和完整性。
Br J Surg. 2013 Sep;100(10):1357-67. doi: 10.1002/bjs.9225.